

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 4mg | 360 pills | A$2.39 | A$1,231.49 A$862.04 Best Price | |
| 4mg | 180 pills | A$2.55 | A$655.30 A$458.71 | |
| 4mg | 120 pills | A$2.66 | A$455.85 A$319.10 | |
| 4mg | 90 pills | A$2.86 | A$367.21 A$257.05 | |
| 4mg | 60 pills | A$3.06 | A$262.73 A$183.91 | |
| 4mg | 30 pills | A$3.37 | A$145.60 A$101.92 | |
| 5mg | 360 pills | A$2.61 | A$1,345.46 A$941.82 | |
| 5mg | 180 pills | A$2.77 | A$712.29 A$498.60 | |
| 5mg | 120 pills | A$2.90 | A$497.01 A$347.91 | |
| 5mg | 90 pills | A$3.12 | A$402.03 A$281.42 | |
| 5mg | 60 pills | A$3.32 | A$284.90 A$199.43 | |
| 5mg | 30 pills | A$3.68 | A$158.26 A$110.78 | |
| 5mg | 10 pills | A$4.43 | A$63.29 A$44.30 | |
| 10mg | 360 pills | A$3.90 | A$2,007.12 A$1,404.98 Popular | |
| 10mg | 180 pills | A$4.14 | A$1,066.86 A$746.80 | |
| 10mg | 120 pills | A$4.34 | A$743.94 A$520.76 | |
| 10mg | 90 pills | A$4.65 | A$598.31 A$418.82 | |
| 10mg | 60 pills | A$4.96 | A$424.19 A$296.93 | |
| 10mg | 30 pills | A$5.47 | A$234.24 A$163.97 | |
| 10mg | 10 pills | A$7.76 | A$110.77 A$77.54 |
Disclaimer: This information is for education and not a substitute for professional medical advice. Always consult your doctor or pharmacist about your personal situation.
Fact: Leukotrienes are inflammatory molecules that contribute to airway narrowing and nasal symptoms in asthma and allergic rhinitis. This biochemical pathway helps explain why some people experience persistent symptoms despite inhaled therapies. Understanding it grounds the use of targeted medicines like montelukast.
Montelukast belongs to a class of oral medicines called leukotriene receptor antagonists. By blocking the receptors for leukotrienes, the drug aims to reduce inflammation in the airways and nasal passages. It is not a rescue medicine for an acute asthma flare, but it can help prevent symptoms when taken regularly.
In Australia, Singulair is one of the well-known brands that contain montelukast. It is often prescribed for adults and children to prevent exercise-induced bronchoconstriction and to manage perennial or seasonal allergic rhinitis, in addition to some asthma symptoms. Your healthcare professional will decide if this medication is right for you based on the pattern of your symptoms and any other conditions you have.
Montelukast is typically taken as a tablet or chewable tablet, and it is taken once daily or as directed by a clinician. The exact dosing schedule depends on age, weight, and the condition being treated. It is important to follow the prescribed plan and to inform your clinician about all medicines you take, including over-the-counter products and supplements.
When used as part of a broader asthma or allergy management plan, montelukast can contribute to reduced nasal congestion, fewer nighttime awakenings due to wheeze or sneezing, and smoother daily activity. It is most effective when used consistently and as part of an overall treatment strategy that may include inhaled therapies and allergen avoidance. If you have questions about whether montelukast will complement your existing regimen, speak with your pharmacist or prescriber.
Montelukast should not be used by people with a known hypersensitivity to montelukast or any of the ingredients in the tablet or chewable form. Severe allergic reactions to montelukast are uncommon but possible, and they require immediate medical attention.
People with rare liver problems or active hepatic disease should be evaluated carefully before starting montelukast, because the medicine is processed in the liver. Your clinician might monitor liver function if they decide montelukast is appropriate for you, especially if you have other risk factors.
If you have a history of significant liver dysfunction, or if you are pregnant or breastfeeding, discuss montelukast with your clinician. The medicine may still be used in some situations, but the benefit-risk balance must be considered carefully by a healthcare professional.
Children with certain metabolic or developmental conditions may require alternative approaches or closer supervision. Do not start montelukast in a child without a clinician’s guidance. If you experience persistent symptoms or a new reaction after starting montelukast, contact your prescriber promptly.
Note: Always tell your clinician about all medicines, vitamins, and supplements you take. If you are currently taking or plan to start any other prescription or OTC medicines, your clinician can assess potential interactions and decide whether montelukast remains the best option for you.
Montelukast can interact with a range of medicines, and some people may notice changes in mood, energy, or sleep patterns while taking it. Regular follow-up with a clinician is advisable to review symptoms, side effects, and the overall effectiveness of therapy.
If you notice mood swings, agitation, restlessness, sleep disturbances, or unusual behavior after starting montelukast, report these changes promptly. While such effects are uncommon, they can occur in some individuals and require assessment by a clinician.
Liver function and blood tests are not always required for every patient, but clinicians may order tests if there is a history of liver disease or if new symptoms arise. Do not assume lab tests are unnecessary; follow your clinician’s guidance on monitoring needs during therapy.
Montelukast can interact with oral contraceptives, some antidepressants, and certain seizure medications, among others. If you start or stop any other prescription medicine, or if your health status changes, seek medical advice to determine whether any adjustment to montelukast is needed.
For people with asthma, montelukast is part of a broader management plan. It should not be used to treat an acute asthma flare or severe allergic reaction. In those situations, seek urgent medical help and use the prescribed rescue inhaler if you have one. Always have an action plan for asthma and know when to step up treatment with your clinician.
Most people tolerate montelukast well. The most frequently reported effects are usually mild and often improve with time. These can include stomach upset or headaches. If these persist or cause significant discomfort, contact your clinician for guidance.
Some individuals report mild feverish sensations or fatigue in the early days of treatment. These symptoms are typically temporary. It is important to monitor how you feel and discuss ongoing symptoms with a healthcare professional to determine whether montelukast remains appropriate for you.
Because montelukast acts on airway inflammation, some users notice changes in nasal congestion or mucus production. These effects are often modest and may improve as treatment continues. If you develop new wheeze, chest tightness, or breathing difficulties, seek medical evaluation promptly.
Allergic-like reactions such as rash or wheal formation around the injection site are not common with montelukast but can occur. Any swelling of the lips, tongue, or throat or signs of anaphylaxis require immediate medical attention.
Gastric discomfort, diarrhea, or abdominal pain have been reported in some patients. These effects are usually mild and temporary. If abdominal symptoms are prolonged, severe, or accompanied by jaundice, seek medical advice.
Serious liver-related symptoms are rare but possible. If you notice unusual tiredness, loss of appetite, dark urine, pale stools, or persistent right upper abdominal pain, inform your clinician promptly so they can assess liver function and adjust therapy if needed.
Rashes, itching, or hives can occur in some individuals. Severe skin reactions are rare but require immediate medical care. Tell your clinician if you notice a worsening skin condition or a swelling that suggests an allergic response.
혈 Though uncommon, some patients report swelling of the face or lips, which can indicate an allergic reaction needing evaluation. If any such symptoms appear, seek urgent medical help right away.
In rare cases, people may notice mood changes, irritability, agitation, aggression, or sleep disturbances. If you or a family member observes persistent changes in behavior, mood, or thinking, discuss these observations with a clinician promptly. Do not stop montelukast suddenly without medical guidance if concerns arise.
Sleep-related issues, including nightmares or vivid dreams, have been reported by some patients. If bedtime disturbances persist or worsen, speak with a healthcare professional to review the treatment plan and determine the best course of action.
Montelukast can interact with certain prescription medicines. In some cases, the combination may require dose adjustments or closer monitoring. Always tell your clinician about all medicines you take, including inhaled corticosteroids, oral steroids, or other asthma control medications.
If you start a new prescription, inform your clinician that you are taking montelukast. They will assess whether any changes to therapy are needed and whether additional monitoring is warranted.
Some OTC products and herbal supplements can interact with montelukast or affect how well it works. Vitamins, minerals, and herbal preparations can influence liver metabolism or interact with other drug pathways. If you regularly take supplements, discuss them with your pharmacist or clinician.
Do not assume an OTC product is safe to take with montelukast without checking first. If you are unsure, seek advice before starting or stopping any supplement alongside montelukast therapy.
Food intake generally does not cause major interactions with montelukast, but some people notice differences in how they feel after meals. There is no fixed rule about taking montelukast with or without food, but follow your clinician’s instruction for consistency.
Alcohol should be used with caution in people taking any prescription medicine, including montelukast. Excessive alcohol use can worsen asthma symptoms for many individuals, and combining alcohol with montelukast is a topic to discuss with your clinician, particularly if you have a history of mood changes or sleep disturbances.
For pregnant people, the decision to use montelukast involves weighing potential benefits against any known risks. Your clinician will consider your asthma control and allergy symptoms as part of this assessment. If you are planning pregnancy or become pregnant while taking montelukast, discuss with your healthcare provider promptly.
Montelukast is not universally contraindicated in pregnancy, but it is essential to have professional guidance. Do not discontinue montelukast abruptly without consulting your clinician, as an asthma or allergy flare could present a risk to both mother and unborn child.
Montelukast passes into breast milk in small amounts. If you are breastfeeding, your clinician will assess whether continuing montelukast is appropriate for you and your baby. Alternate strategies may be considered if there are concerns about infant exposure or if the infant has special health needs.
Do not stop treatment without talking to a clinician. If montelukast is essential for your asthma or allergy control, your clinician can provide guidance on safe planning around feeding and infant health monitoring.
Older adults may have additional medical considerations, such as other chronic illnesses or polypharmacy. A clinician may adjust monitoring frequency or review concomitant medications to avoid potential interactions or liver-related concerns.
As with all medicines, safety and effectiveness depend on individual health status. If you notice new symptoms or unusual reactions after starting montelukast, report these changes to your clinician promptly.
Montelukast is used in children and adolescents for asthma prevention and allergy symptoms, but pediatric use requires careful dosing and monitoring. Parents and carers should watch for mood or behavior changes, sleep disturbances, or new rashes, and report these promptly to the child’s clinician.
If a child experiences severe wheezing, chest tightness, or difficulty breathing, treat this as a medical concern and seek urgent medical help as indicated by the child’s action plan and clinician guidance.
Montelukast is typically prescribed to be taken once daily, at a consistent time, as directed by the clinician. Do not alter the schedule without consulting a healthcare professional, as inconsistent use can reduce benefits for asthma and allergy control.
Swallow tablets whole with water, unless the product is a chewable form prescribed for a child. If a dose is missed, follow the clinician’s guidance on what to do next rather than doubling the dose to catch up.
Keep a regular routine and use montelukast as part of a broader management plan for asthma or allergic rhinitis. Do not rely on montelukast to treat an acute asthma attack or a severe allergic reaction; have a rescue plan and access to appropriate emergency care if symptoms escalate.
Store montelukast at the room temperature specified on the label, away from moisture and heat. Do not share your medication with others, even if their symptoms seem similar, as individual dosing and medical history matter for safety and effectiveness.
Inform your pharmacist if you have kidney or liver disease, or if you are taking other medicines that could interact. Ongoing communication with your healthcare team helps ensure the most suitable approach is maintained over time.
If you notice signs of a severe allergic reaction, such as swelling of the face or throat, severe rash with blistering, or difficulty breathing, seek urgent medical help immediately. These events require rapid evaluation and treatment.
Persistent mood changes, agitation, aggression, or thoughts of self-harm are important safety signals. If you, or someone you care for, experiences these symptoms, contact a clinician promptly and consider safety planning with a healthcare professional.
Any new or worsening symptoms such as persistent vomiting, severe abdominal pain, jaundice, or pale stools may indicate liver-related concerns. Report these symptoms to a clinician without delay for assessment and, if necessary, test planning.
If symptoms of asthma or allergy worsen or do not improve after starting montelukast, arrange a follow-up with your clinician. A failure to achieve expected control may signal the need to adjust therapy, add a different treatment, or revisit the diagnosis.
Introductory note: The following Q&A focuses on safety considerations and practical scenarios. If you are unsure about any information, confirm with your clinician or pharmacist. Dosing details are not provided here; always follow official medical advice.
Q&A below uses plain language to cover common concerns about montelukast in everyday Australian care settings.
For people with ongoing health issues or if you are unsure about a specific situation, consult your healthcare professional before making changes to your treatment plan.
Montelukast may be considered in some cases during pregnancy when the potential benefits justify the risks. A clinician will weigh this balance based on your asthma or allergy control and overall health. Do not start or stop montelukast on your own if you are pregnant or planning pregnancy.
Breastfeeding considerations depend on infant exposure and maternal health needs. If montelukast is essential for managing symptoms, your clinician can offer guidance on timing and monitoring for the baby. Do not change or discontinue therapy without professional advice.
Neuropsychiatric effects have been reported in rare cases. If you notice mood changes, sleep disturbances, irritability, or unusual behavior, inform your clinician, who can evaluate the risk-benefit balance and adjust treatment if needed.
Moderate to heavy alcohol use can worsen asthma control in some individuals. While there is no universal contraindication, speak with your clinician about any concerns and adapt your management plan accordingly.
Some supplements can alter how montelukast is processed by the body or interact with other medications. Always disclose all supplements to your clinician, who can assess potential interactions and safety risks.
Routine blood tests are not always required for every patient. But if you have liver disease, symptoms suggestive of liver problems, or if you take other medicines that affect the liver, your clinician might order monitoring. Follow their recommendations and report any new symptoms promptly.
If you do not notice improvement after a reasonable period, talk to your clinician. They may adjust the dose, switch therapies, or add another treatment to better control symptoms. Do not stop montelukast on your own without professional guidance.
Discontinuation should be guided by your clinician. Some people may need to continue therapy long-term to maintain control; stopping without advice risks a relapse of symptoms. Discuss a plan for gradual cessation if appropriate.
Montelukast is commonly used in younger patients under medical supervision. The safety profile is generally favorable when used as prescribed, but clinicians monitor for age-related differences in response and potential side effects. Parents should report mood or behavior changes promptly.
Persistent asthma symptoms, increased nighttime awakenings, more frequent wheeze, new shortness of breath, or significant adverse effects should prompt a clinical review. A sudden or severe change in symptoms requires professional assessment, even if you recently started montelukast.
Yes, montelukast is often used in addition to inhaled therapies, including rescue inhalers for quick relief. Your clinician will coordinate these therapies to avoid duplication and ensure effective control of symptoms.
Serious organ toxicity is rare. If you notice unusual fatigue, yellowing of the skin or eyes, severe abdominal pain, or other unexpected symptoms, seek medical advice promptly for a proper evaluation.
Store montelukast at room temperature away from excessive heat and moisture. Keep it out of reach of children and dispose of any unused medication according to local guidelines or pharmacist advice.
Always start with the official patient information leaflet that accompanies your medication. For Australia, sources such as the Therapeutic Goods Administration (TGA) and national patient information services can provide up-to-date safety guidance and regulatory notices. Your pharmacist is a first point of contact for questions about interactions, dosing within your regimen, and any adverse effects you experience.
Trusted medical information sources include national health services and professional bodies. If you need practical advice tailored to your situation, a licensed clinician or pharmacist can help interpret information in the context of your health history.
Remember that this page is educational and not a substitute for personalised medical advice. If you have questions about montelukast, its safety, or whether it is suitable for you, consult a healthcare professional.
For ongoing concerns, keep a simple symptom diary and bring it to your next appointment with your clinician. Clear communication about how montelukast affects daily life helps refine your treatment plan and safety monitoring.
- Therapeutic Goods Administration (TGA) in Australia for approved medicines and safety communications.
- National health information and patient support services for asthma and allergy management.
- Your local pharmacist and clinician who can provide personalised guidance based on your medical history.
14–21 days. Free from A$285.95 .
5–9 days. A$42.89
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
